CompaniesBHR Pharma

BHR Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

1,607

By Phase

PHASE3: 3PHASE2: 2

By Status

TERMINATED: 3COMPLETED: 2
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT01143064
NCT02349386
NCT02993159
Hover over trial bars to see details

Recent Trials

NCT03199963Lead Sponsor
Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue
PHASE3Terminated
223 participants
Started: Aug 21, 2017 · Completed: Apr 23, 2019
NCT03202186Lead Sponsor
Study of Progesterone in Treatment of Vasomotor Symptoms
PHASE3Terminated
55 participants
Started: Aug 1, 2017 · Completed: Dec 6, 2018
NCT02993159Collaborator
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
PHASE2Completed
100 participants
Started: May 31, 2017 · Completed: Jan 24, 2022
NCT02349386Lead Sponsor
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
PHASE2Terminated
34 participants
Started: Jul 31, 2015 · Completed: Jan 10, 2018
NCT01143064Lead Sponsor
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
PHASE3Completed
1,195 participants
Started: Jun 30, 2010 · Completed: Mar 31, 2014
Related Companies
Besins----------------------------------------if You Believe Any Of This Information Is Incorrect
subsidiary